Loading...

Assertio Holdings, Inc.

ASRTNASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$0.79
$0.02(2.29%)

Assertio Holdings, Inc. (ASRT) Financial Performance & Income Statement Overview

View comprehensive annual and quarterly summaries for Assertio Holdings, Inc. (ASRT), featuring income statements, balance sheets, and cash flow data.

Revenue Growth
-17.83%
17.83%
Operating Income Growth
89.95%
89.95%
Net Income Growth
93.50%
93.50%
Operating Cash Flow Growth
-46.76%
46.76%
Operating Margin
-32.27%
32.27%
Gross Margin
67.87%
67.87%
Net Profit Margin
-36.46%
36.46%
ROE
-37.66%
37.66%
ROIC
-26.75%
26.75%

Assertio Holdings, Inc. (ASRT) Income Statement & Financial Overview

Explore comprehensive income reports for Assertio Holdings, Inc. ASRT, broken down by year and quarter.

MetricQ1 2025Q4 2024Q3 2024Q2 2024
Revenue$26.49M$32.18M$29.20M$31.13M
Cost of Revenue$7.79M$11.61M$7.55M$8.89M
Gross Profit$18.70M$20.57M$21.65M$22.24M
Gross Profit Ratio$0.71$0.64$0.74$0.71
R&D Expenses$438000.00$1.29M$1.005M$798000.00
SG&A Expenses$21.98M$21.52M$16.73M$18.39M
Operating Expenses$31.93M$34.05M$24.70M$25.85M
Total Costs & Expenses$39.72M$46.38M$32.25M$34.74M
Interest Income$720000.00$780000.00$887000.00$842000.00
Interest Expense$765000.00$763000.00$761000.00$758000.00
Depreciation & Amortization$0.00$6.71M$6.71M$6.71M
EBITDA-$13.23M-$3.27M$4.59M$3.94M
EBITDA Ratio-$0.50-$0.10$0.16$0.13
Operating Income-$13.23M-$13.47M-$3.05M-$3.62M
Operating Income Ratio-$0.50-$0.42-$0.10-$0.12
Other Income/Expenses (Net)-$63000.00$2.73M$171000.00$92000.00
Income Before Tax-$13.30M-$10.75M-$2.88M-$3.52M
Income Before Tax Ratio-$0.50-$0.33-$0.10-$0.11
Income Tax Expense-$245000.00-$273000.00$44000.00$149000.00
Net Income-$13.05M-$10.48M-$2.92M-$3.67M
Net Income Ratio-$0.49-$0.33-$0.10-$0.12
EPS-$0.14-$0.11-$0.03-$0.04
Diluted EPS-$0.14-$0.11-$0.03-$0.04
Weighted Avg Shares Outstanding$95.68M$95.51M$95.35M$95.24M
Weighted Avg Shares Outstanding (Diluted)$95.68M$95.51M$95.35M$95.24M

Over the last four quarters, Assertio Holdings, Inc. achieved steady financial progress, growing revenue from $31.13M in Q2 2024 to $26.49M in Q1 2025. Gross profit stayed firm with margins at 71% in Q1 2025 versus 71% in Q2 2024. Operating income totaled -$13.23M in Q1 2025, maintaining a -50% margin over recent quarters. Despite shifts in R&D and SG&A costs, EBITDA stayed strong at -$13.23M. Net income dropped to -$13.05M, with EPS at -$0.14. Disciplined expense strategies and efficient operations ensured sustained profitability and long-term financial stability.

Unlock 25+ Years of Financial Data

Get access to extended historical data, advanced metrics, and more with our premium plan

Frequently Asked Questions

;